Kronos Bio, Inc.
DelistedCIK 1741830fmd_04CF04AEPGC5W5KQ0BF6M2BDT8Manufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 01, 2018 to Mar 31, 2025, 26 periods
| Line item | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|---|---|
| Total revenues | – | – | – | – | 0 | 6 | 10 |
| Research and development | 5 | 13 | 43 | 113 | 94 | 85 | 49 |
| Total operating expenses | 7 | 17 | 58 | 151 | 137 | 128 | 103 |
| Operating income | (7) | (17) | (58) | (151) | (137) | (122) | (93) |
| Interest expense | 0 | 0 | 4 | 0 | – | – | – |
| Other non-operating income (expense) | (0) | 1 | (30) | 0 | 4 | 9 | 7 |
| Income tax expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income | (7) | (16) | (88) | (151) | (133) | (113) | (86) |